CompletedNot applicableNCT02884219
Early Treatment Versus Expectative Management of PDA in Preterm Infants
Studying Arterial duct anomaly
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Radboud University Medical Center
- Principal Investigator
- Willem P de Boode, MD PhD, MDRadboud University Medical Center
- Intervention
- Ibuprofen(drug)
- Enrollment
- 273 enrolled
- Eligibility
- All sexes
- Timeline
- 2016 – 2022
Study locations (13)
- University Hospital Antwerp, Antwerp, Belgium
- Hôpital Erasme - Clinique Universitaires de Bruxelles, Brussels, Belgium
- University Hospital Brussels, Brussels, Belgium
- Academic Medical Center, Amsterdam, Netherlands
- Free University Amsterdam, Amsterdam, Netherlands
- University Medical Center Groningen, Groningen, Netherlands
- Leiden University Medical Center, Leiden, Netherlands
- Maatricht University Medical Center, Maastricht, Netherlands
- Radboudumc Amalia Children's Hospital, Nijmegen, Netherlands
- Erasmus Medical Center Rotterdam, Rotterdam, Netherlands
- Wilhelmina Children's Hospital/UMCU, Utrecht, Netherlands
- Maxima Medical Center, Veldhoven, Netherlands
- Isala Kliniek Zwolle, Zwolle, Netherlands
Collaborators
ZonMw: The Netherlands Organisation for Health Research and Development
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT02884219 on ClinicalTrials.govOther trials for Arterial duct anomaly
Additional recruiting or active studies for the same condition.
- ACTIVE NOT RECRUITINGNCT06950164Dynamic Changes of Ductus Arteriosus in < 31 Weeks Preterm Infants: an Observational StudyDaping Hospital and the Research Institute of Surgery of the Third Military Medical University
- RECRUITINGNCT06658496PDA for Kidneys StudyUniversity of Wisconsin, Madison
- RECRUITINGNCT06646250NeoDoppler: New Ultrasound Technology for Continuous Monitoring of Cerebral Circulation PilotSt. Olavs Hospital
- RECRUITINGPHASE2NCT07143201Precision Dosing of Oral Ibuprofen for PDA, A Pilot RCTHamilton Health Sciences Corporation
- RECRUITINGNCT05264753Post Marketing Clinical Follow Up Study to Evaluate Efficacy and Safety of the Occlutech PDA Occluder in Patients With Patent Ductus Arteriosus DefectsOcclutech International AB
- ACTIVE NOT RECRUITINGNCT04371081Amplatzer Piccolo Occluder Japan Post-marketing Database SurveillanceAbbott Medical Devices
- ENROLLING BY INVITATIONNANCT04667455Improving Care for Children With Congenital Heart Disease.Lund University Hospital
- ACTIVE NOT RECRUITINGNCT03782610Early Prediction of Spontaneous Patent Ductus Arteriosus (PDA) Closure and PDA-Associated OutcomesNationwide Children's Hospital